Dabigatran

Use of Dabigatran

Harness the power of Dabigatran capsules, a leading anticoagulant medication prescribed to prevent blood clots and reduce the risk of stroke in patients with atrial fibrillation. Dabigatran offers effective protection against thromboembolic events, providing peace of mind for individuals at risk of clot-related complications.

Dabigatran, a direct thrombin inhibitor, works by specifically targeting and inhibiting thrombin, a key enzyme involved in the blood clotting process. By preventing the formation of blood clots, Dabigatran helps maintain blood flow and reduces the risk of clot-related events such as stroke and systemic embolism.

Precautions and Warnings

• Avoid Dabigatran in individuals with a history of hypersensitivity to the medication.
• Use caution in patients with renal impairment, as dosage adjustments may be necessary to prevent excessive anticoagulation.
• Inform healthcare providers about any ongoing medications, particularly other anticoagulants, to minimize the risk of drug interactions.
• Dabigatran should be used with caution in patients at an increased risk of bleeding, such as those with a history of gastrointestinal bleeding or recent surgery.

Dosage

The recommended dosage of Dabigatran depends on the patient’s indication for anticoagulation:

• For stroke prevention in atrial fibrillation, the typical dose is 150 mg orally twice daily, with adjustments for renal function.
• In the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), the initial dose is 150 mg twice daily after a period of parenteral anticoagulation.

Side Effects

Common side effects:

• Gastrointestinal discomfort
• Nausea
• Dyspepsia
• Bleeding
• Bruising
• Rash
• Liver enzyme elevation